Search
Search filters
Type
Audience
Category
Issue
Last updated
- 20231 results available
- 20222 results available
- 20216 results available
- 20181 results available
- 20162 results available
- 20151 results available
- 20131 results available
- 20122 results available
- 20091 results available
- 20072 results available
- 20063 results available
- 20053 results available
- 20042 results available
- 20031 results available
- 20023 results available
- 20011 results available
Recall class
Displaying 31 - 32 of 32 items.
EVUSHELD (tixagevimab and cilgavimab for injection) - Risk of Prophylaxis or Treatment Failure due to Antiviral Resistance
AlertHealth professional risk communication | 2022-10-26
EVUSHELD (tixagevimab and cilgavimab for injection) - Risk of Prophylaxis or Treatment Failure due to Antiviral Resistance to specific SARS-CoV-2 Subvariants
AlertHealth professional risk communication | 2023-01-17